The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment

被引:7
|
作者
Kim, Hyung-Ji [1 ,2 ]
Oh, Jungsu S. [3 ]
Lim, Jae-Sung [1 ]
Lee, Sunju [1 ]
Jo, Sungyang [1 ]
Chung, E-Nae [4 ,5 ]
Shim, Woo-Hyun [4 ,5 ,6 ]
Oh, Minyoung [3 ]
Kim, Jae Seung [3 ]
Roh, Jee Hoon [7 ,8 ]
Lee, Jae-Hong [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Neurol, Coll Med, Seoul, South Korea
[2] Eulji Univ, Uijeongbu Eulji Med Ctr, Dept Neurol, Sch Med, Uijongbu, South Korea
[3] Univ Ulsan, Dept Nucl Med, Coll Med, Asan Med Ctr, Seoul, South Korea
[4] Univ Ulsan, Asan Med Ctr, Hlth Innovat Bigdata Ctr, Asan Inst Lifesci,Dept Radiol,Coll Med, Seoul, South Korea
[5] Univ Ulsan, Asan Med Ctr, Res Inst Radiol, Coll Med, Seoul, South Korea
[6] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea
[7] Korea Univ, Neurosci Inst, Coll Med, Seoul, South Korea
[8] Sch Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Amyloid; Dementia; Disease progression; Mild cognitive impairment; ALZHEIMER-DISEASE; RISK-FACTORS; PET IMAGES; BETA; TAU; DECLINE; PATHOLOGY; RATES;
D O I
10.1186/s13195-022-01035-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background About 40-50% of patients with amnestic mild cognitive impairment (MCI) are found to have no significant Alzheimer's pathology based on amyloid PET positivity. Notably, conversion to dementia in this population is known to occur much less often than in amyloid-positive MCI. However, the relationship between MCI and brain amyloid deposition remains largely unknown. Therefore, we investigated the influence of subthreshold levels of amyloid deposition on conversion to dementia in amnestic MCI patients with negative amyloid PET scans. Methods This study was a retrospective cohort study of patients with amyloid-negative amnestic MCI who visited the memory clinic of Asan Medical Center. All participants underwent detailed neuropsychological testing, brain magnetic resonance imaging, and [F-18]-florbetaben (FBB) positron emission tomography scan (PET). Conversion to dementia was determined by a neurologist based on a clinical interview with a detailed neuropsychological test or a decline in the Korean version of the Mini-Mental State Examination score of more than 4 points per year combined with impaired activities of daily living. Regional cortical amyloid levels were calculated, and a receiver operating characteristic (ROC) curve for conversion to dementia was obtained. To increase the reliability of the results of the study, we analyzed the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset together. Results During the follow-up period, 36% (39/107) of patients converted to dementia from amnestic MCI. The dementia converter group displayed increased standardized uptake value ratio (SUVR) values of FBB on PET in the bilateral temporal, parietal, posterior cingulate, occipital, and left precuneus cortices as well as increased global SUVR. Among volume of interests, the left parietal SUVR predicted conversion to dementia with the highest accuracy in the ROC analysis (area under the curve [AUC] = 0.762, P < 0.001). The combination of precuneus, parietal cortex, and FBB composite SUVRs also showed a higher accuracy in predicting conversion to dementia than other models (AUC = 0.763). Of the results of ADNI data, the SUVR of the left precuneus SUVR showed the highest AUC (AUC = 0.596, P = 0.006). Conclusion Our findings suggest that subthreshold amyloid levels may contribute to conversion to dementia in patients with amyloid-negative amnestic MCI.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Elevation of β-Amyloid 1-42 Autoantibodies in the Blood of Amnestic Patients With Mild Cognitive Impairment
    Storace, Daniela
    Cammarata, Sergio
    Borghi, Roberta
    Sanguineti, Roberta
    Giliberto, Luca
    Piccini, Alessandra
    Pollero, Valeria
    Novello, Cristina
    Caltagirone, Carlo
    Smith, Mark A.
    Bossu, Paola
    Perry, George
    Odetti, Patrizio
    Tabaton, Massimo
    ARCHIVES OF NEUROLOGY, 2010, 67 (07) : 867 - 872
  • [42] Plasma amyloid beta peptides levels in sporadic Alzheimer's disease and amnestic mild cognitive impairment
    Sobow, T
    Kloszewska, I
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 357 - 357
  • [43] Imaging of amyloid plaques and cerebral glucose metabolism in amnestic mild cognitive impairment
    Choo, Il Han
    Kim, Yu Kyeong
    Lee, Dong Young
    Kim, Su Jin
    Lee, Jae Sung
    Lee, Dong Soo
    Woo, Jong Inn
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [44] Prediction of Amyloid-β Pathology in Amnestic Mild Cognitive Impairment with Neuropsychological Tests
    Bahar-Fuchs, Alex
    Villemagne, Victor
    Ong, Kevin
    Chetelat, Gael
    Lamb, Fiona
    Reininger, Cornelia B.
    Woodward, Michael
    Rowe, Christopher C.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (02) : 451 - 462
  • [45] Comparison of event-related potential markers in amyloid positive vs. amyloid negative patients with mild cognitive impairment (MCI) and dementia
    Levy, I.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [46] Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study
    Hanon, Olivier
    Vidal, Jean-Sebastien
    Lehmann, Sylvain
    Bombois, Stephanie
    Allinquant, Bernadette
    Baret-Rose, Christiane
    Treluyer, Jean-Marc
    Abdoul, Hendy
    Gele, Patrick
    Delmaire, Christine
    Blanc, Frederic
    Mangin, Jean-Francois
    Buee, Luc
    Touchon, Jacques
    Hugon, Jacques
    Vellas, Bruno
    Galbrun, Evelyne
    Benetos, Athanase
    Berrut, Gilles
    Paillaud, Elena
    Wallon, David
    Castelnovo, Giovanni
    Volpe-Gillot, Lisette
    Paccalin, Marc
    Robert, Philippe
    Godefroy, Olivier
    Camus, Vincent
    Belmin, Joel
    Vandel, Pierre
    Novella, Jean-Luc
    Duron, Emmanuelle
    Rigaud, Anne-Sophie
    Schraen-Maschke, Susanna
    Gabelle, Audrey
    ALZHEIMERS & DEMENTIA, 2022, 18 (12) : 2537 - 2550
  • [47] In vivo distribution of amyloid plaque deposition in mild cognitive impairment
    DeKosky, Steven T.
    Mathis, Chester A.
    Price, Julie C.
    Lopresti, Brian J.
    Meltzer, Carolyn C.
    Ziolko, Scott K.
    Hoge, Jessica A.
    Tsopelas, Nicholas
    Klunk, William E.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S198 - S199
  • [48] Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment
    Young Hee Jung
    Seongbeom Park
    Hyemin Jang
    Soo Hyun Cho
    Seung Joo Kim
    Jun Pyo Kim
    Sung Tae Kim
    Duk L. Na
    Sang Won Seo
    Hee Jin Kim
    Scientific Reports, 10
  • [49] Prediction of conversion to dementia using interpretable machine learning in patients with amnestic mild cognitive impairment
    Chun, Min Young
    Park, Chae Jung
    Kim, Jonghyuk
    Jeong, Jee Hyang
    Jang, Hyemin
    Kim, Kyunga
    Seo, Sang Won
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [50] Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment
    Jung, Young Hee
    Park, Seongbeom
    Jang, Hyemin
    Cho, Soo Hyun
    Kim, Seung Joo
    Kim, Jun Pyo
    Kim, Sung Tae
    Na, Duk L.
    Seo, Sang Won
    Kim, Hee Jin
    SCIENTIFIC REPORTS, 2020, 10 (01)